Histopathologic assessment of pancreatic cancer: Does one size fit all
Journal of Surgical Oncology, 06/26/2012
Reid MD et al. – Because these tumors are often combined with pancreatic tumors are invasive ductal adenocarcinoma (PDAC) in research databases, it causes misleading variability in the analysis of pancreatic cancers. They examine the histopathology of a variety of pancreatic cancers.